Major industries relating to inventions in marine biotechnology increasingly apply for patents. Most
patents are applied for inventions that are derived from terrestrial biotechnology. However, it is
recognized that marine biotechnology offers a high potential to yield inventions as well. Marine
biotechnology can be divided into two main areas. First, development of commercially viable drugs
obtained from marine bioprospecting and, second, development of marine genetically modified
organisms for aquacultural and environmental purposes.
A patent means intellectual protection for an invention. Intellectual protection confers the exclusive
right upon the patent holder to sell the right of utilization of the invention to interested parties. The
selling of licenses provide one important way of receiving revenues for the research done for the
invention. The prospect of potential revenues provide the incentive for investment into biotechnological
research and subsequent patenting of inventions arising thereof.
The overall aim of this work is to illustrate the close interrelationship of science and law by using
marine biotechnology and patents as an example.
Section two provides an overview on the scientific side of marine biotechnology. It will define
marine biotechnology and investigate current advancements in marine biotechnology. Additionally, it
roughly explains the international patent system governing inventions in the biotechnological area and
provide examples on patents related to marine biotechnology.
Section three illustrates the criticism expressed against life form patents in marine as well as
terrestrial biotechnology. It will describe the most important cases that have fueled controversial
debates on life form patents until today.
[...]
Table of Contents
1. Introduction
2. Marine biotechnology
2.1 Scientific background
2.2 Patent background
3. Patents on life forms
3.1 General concerns
3.2 Landmark cases
4. Conclusions
Objectives and Topics
This work explores the complex intersection between scientific advancements in marine biotechnology and the legal frameworks governing intellectual property. It aims to demonstrate how patent systems, originally designed for industrial applications, navigate the unique challenges posed by the patenting of life forms and biological material.
- Scientific foundations of marine biotechnology and its commercial applications.
- The role of the international patent system in incentivizing biotechnological research.
- Ethical and moral controversies surrounding the patenting of genetically modified organisms.
- Legal analysis of landmark cases, including the Chakrabarty microbe and the Oncomouse.
- Regulatory considerations regarding human health and environmental impact.
Excerpt from the Book
3.2 Landmark cases
The general anticipation before the 1980s was that biotechnological processes, such as recombinant DNA technology, could be patented but organisms as they occur in nature cannot be considered patentable. This situation began to change in 1980 with the US Supreme Court decision in Diamond v. Chakrabarty which allowed the patenting of the oil-degrading micro-organism. The patent was initially rejected by the US Patent and Trademark Office reasoning that “as living things, microbes are not patentable subject matter”. The patent rejection was brought to the Court of Customs and Patent Appeals. Already in 1977 the same court had granted a patent on a pure culture of naturally occurring Streptomyces bacteria producing antibiotics. The court held that biologically pure cultures of micro-organisms do not exist in nature and could be patentable. The court further stated that micro-organisms, although alive, are much more akin to inanimate chemical compounds than to other living organisms.
Unsurprisingly, the court overruled the patent rejection of the Chakrabarty micro-organism in 1978. The court held that there is 'no legally significant difference between active chemicals which are classified as “dead” and organisms used for their chemical reactions which take place because they are “alive”'. In 1980, the Patent and Trademark Office Supreme Court appealed against the ruling of the Court of Customs and Patent Appeals at the US Supreme Court. The US Supreme Court rejected the appeal. It considered Title 35 United States Code § 101 which describes inventions patentable being “any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof”. The expansive terms “any”, “manufacture”, and “composition of matter” provide a wide scope of inventions patentable. The introduced characteristics changed the Chakrabarty micro-organism into a nonnaturally manufacture or composition of matter having a distinct name, character, and use. The court further included the statement accompanying the 1952 Patent Act, where Congress intended patentable matter to “include anything under the sun that is made by man.”
Summary of Chapters
1. Introduction: This chapter introduces the significance of marine biotechnology and outlines the fundamental relationship between scientific innovation and the patent protection necessary to incentivize such costly research.
2. Marine biotechnology: This section details the scientific scope of marine biotechnology, including drug development and bioremediation, while explaining the international patent system's requirements for novelty and industrial application.
3. Patents on life forms: This chapter analyzes the ethical controversies and legal disputes surrounding the patenting of living organisms, focusing on how courts have grappled with the definition of "inventions" versus "products of nature."
4. Conclusions: This section summarizes the interdependence of science and law, noting that while patents drive research, they must operate within a broader regulatory structure that addresses moral, environmental, and health-related concerns.
Keywords
Marine biotechnology, Patents, Intellectual Property Rights, TRIPs Agreement, Genetic engineering, Recombinant DNA, Micro-organisms, Life form patents, Chakrabarty, Oncomouse, Bioprospecting, Bioremediation, Patent law, Innovation, Transgenic organisms
Frequently Asked Questions
What is the primary focus of this work?
The work examines the relationship between marine biotechnology and the legal mechanisms that protect inventions in this field, specifically focusing on the challenges of patenting life forms.
What are the central thematic areas covered?
The paper covers the scientific background of marine biotechnology, the fundamentals of the international patent system, and the ethical disputes surrounding the patentability of genetically modified organisms.
What is the core research objective?
The aim is to illustrate the close interrelationship between science and law by using marine biotechnology and patent law as a concrete example.
Which scientific methodology is employed?
The author uses a descriptive and analytical approach, combining scientific context with a review of relevant legal statutes and landmark court cases regarding biotechnology patents.
What topics are discussed in the main body of the text?
The main body treats the definition and advancements in marine biotechnology, the legal requirements for obtaining patents under the TRIPs agreement, and detailed case studies like the Chakrabarty microbe and the Oncomouse.
Which keywords best characterize this research?
Key terms include marine biotechnology, patent law, intellectual property, transgenic organisms, and moral/ethical controversy in the life sciences.
Why was the Chakrabarty case significant for biotechnology patents?
It was a landmark case in 1980 that shifted legal precedent by allowing the patenting of a genetically modified micro-organism, effectively establishing that "anything under the sun made by man" could be considered patentable subject matter.
How does the author view the role of the patent system in scientific progress?
The author suggests that while patents are essential for incentivizing expensive biotechnological research, they are not a standalone solution and must coexist with other regulatory frameworks regarding health, environment, and morality.
- Citar trabajo
- M.Sc. Bevis Fedder (Autor), 2008, Marine Biotechnology and Patents, Múnich, GRIN Verlag, https://www.grin.com/document/120146
